Official government website of the Government of the Kingdom of Saudi ArabiaHow is it achieved?

The Saudi official educational websites' links end with edu.sa

Check the domain's scope in the browser's address bar before sharing your data.

Trusted government websites use a protocol HTTPS

Check that the site uses HTTPS protocol to encrypt the connection.

Digital Government Authority Registered with the Digital Government Authority with no: 20260416249

What are you looking for?

Faculty members

Content

Inside a building, a man dressed in a traditional white uniform with a red and white Saudi shemagh wears a neutral expression as if he were taking a picture of a faculty file at Qassim University.
Photo of the faculty member

FARIS FAHAD A ABA ALKHAYL

Associate Professor
College of Applied Medical Sciences
section

Personal data

    Scientific qualifications

      Research interests

        Published research

        • The effect of krill oil supplementation on skeletal muscle function and size in older adults: A randomized controlled trial (2022-01-01)
        • Advances in Designing Polymeric Micelles for Biomedical Applications in Brain-Related Diseases (2022-01-01)
        • The effect of short-duration resistance training on insulin sensitivity and muscle adaptations in overweight men (2019-01-01)
        • Mechanistic insights into alkaloid-based inhibition of squalene epoxidase: a combined in silico and experimental approach for targeting cholesterol biosynthesis (2025-01-01)
        • Multifaceted role of synbiotics as nutraceuticals, therapeutics, and carriers for drug delivery (2022-01-01)
        • Bridging in silico and in vitro perspectives to unravel molecular mechanisms underlying the inhibition of β-glucuronidase by coumarins from Hibiscus trionum (2024-01-01)
        • Dynamic interactions and inhibitory mechanisms of Artemisia annua terpenoids with carbonic anhydrase IX (2024-01-01)
        • Dissecting molecular mechanisms underlying the inhibition of β-glucuronidase by alkaloids from Hibiscus trionum: Integrating in vitro and in silico perspectives (2024-01-01)
        • Unraveling molecular mechanisms of β-glucuronidase inhibition by flavonoids from Centaurea scoparia: integrated in silico and in vitro insights (2024-01-01)
        • Mechanistic insights into β-glucuronidase inhibition by isoprenylated flavonoids from Centaurea scoparia: bridging experimental and computational approaches (2025-01-01)
        • Unraveling the mechanism of carbonic anhydrase IX inhibition by alkaloids from Ruta chalepensis: A synergistic analysis of in vitro and in silico data (2024-01-01)
        • Discovery of novel inhibitors from medicinal plants for v-domain ig suppressor of t-cell activation (2021-01-01)
        • An overview of biomedical applications for gold nanoparticles against lung cancer (2023-01-01)
        • Inhibitory Mechanisms of β-Glucuronidase by Hibiscus syriacus Phenolics: Integrating Computational and Experimental Approaches (2025-01-01)
        • Discovery of Rift Valley fever virus natural pan-inhibitors by targeting its multiple key proteins through computational approaches (2022-01-01)
        • Garlic Extract alleviates Trastuzumab-Induced hepatotoxicity in rats through its Antioxidant, anti-inflammatory, and Antihyperlipidemic effects (2021-01-01)
        • Novel drug discovery: Advancing Alzheimer's therapy through machine learning and network pharmacology (2024-01-01)
        • Expanding arsenal against diabetic wounds using nanomedicines and nanomaterials: Success so far and bottlenecks (2022-01-01)
        • Mycosynthesis of zinc oxide nanoparticles using Mucor racemosus with their antimicrobial, antibiofilm, anticancer and antioxidant activities (2025-01-01)
        • Kaempferitrin inhibits colorectal cancer cells by inducing reactive oxygen species and modulating the PI3K/AKT signaling pathway. (2022-01-01)
        • Core-proteomics-based annotation of antigenic targets and reverse-vaccinology-assisted design of ensemble immunogen against the emerging nosocomial infection-causing bacterium … (2021-01-01)
        • A microemulsion-based gel of isotretinoin and erythromycin estolate for the management of acne (2022-01-01)
        • An in silico hierarchical approach for drug candidate mining and validation of natural product inhibitors against pyrimidine biosynthesis enzyme in the antibiotic-resistant … (2022-01-01)
        • Cannabinoids in neuropathic pain treatment: pharmacological insights and clinical outcomes from recent trials (2025-01-01)
        • Mechanism-based Inhibition of aldose reductase by natural xanthones: computational and experimental insights for diabetic complications (2025-01-01)
        • β-Glucuronidase Inhibition in Drug Development: Emerging Strategies for Mitigating Drug-Induced Toxicity and Enhancing Therapeutic Outcomes (2025-01-01)
        • The impact of the time of day on metabolic responses to exercise in adults: a systematic and meta-analysis review (2024-01-01)
        • Prospective role of bioactive molecules and exosomes in the therapeutic potential of camel milk against human diseases: an updated perspective (2022-01-01)
        • Design of a Multi-Epitope-Based Chimeric Vaccine against Enterobacter cloacae Using Pan-Genome and Reverse Vaccinology Approaches (2022-01-01)
        • Targeting the Skp2–Cks1 protein–protein interaction: structures, assays, and preclinical inhibitors (2025-01-01)
        • Muscle protein synthesis and muscle/metabolic responses to resistance exercise training in South Asian and White European men (2022-01-01)
        • Recent developments in the formulation of zolmitriptan for migraine therapy: production, metabolism and pharmaceutical aspects (2025-01-01)
        • Uncoupling toxic no signaling: Progress, challenges, and therapeutic promise of disrupting the psd-95/nnos protein–protein interaction (2025-01-01)
        • In vitro and In silico mechanistic insights into PTP1B inhibition by sulfated flavonoids from Flaveria bidentis (2025-01-01)
        • Repurposing dual-C-prenylated flavonoids as potent allosteric inhibitors of PTP1B: Integrated phytochemical, enzymological, and in silico evidence (2025-01-01)
        • Targeting the ATG12–ATG3 protein-protein interaction: From structural insights to therapeutic opportunities in autophagy modulation (2025-01-01)
        • Comprehensive insights into carbonic anhydrase inhibition: A triad of in vitro, in silico, and in vivo perspectives (2025-01-01)
        • Breaking the oncogenic alliance: advances in disrupting the MTDH–SND1 complex for cancer therapy (2025-01-01)
        • Watercress-derived glucosinolates as potential allosteric PTP1B inhibitors: a dual in silico and in vitro study on insulin signaling modulation (2025-01-01)
        • Disrupting the Hsp90–Cdc37 axis: a selective strategy for targeting oncogenic kinases in cancer (2025-01-01)
        • Unlocking the unexplored medicinal values of the red listed South African weed Erigeron bonariensis: from ethnobotany to biomedicine (2023-01-01)
        • Insights into the binding of receptor-binding domain (RBD) of SARS-CoV-2 wild type and B. 1.620 variant with hACE2 using molecular docking and simulation approaches (2021-01-01)
        • Multidimensional insights into squalene epoxidase drug development: in vitro mechanisms, in silico modeling, and in vivo implications (2025-01-01)
        • Multi-pronged approaches to the mechanism-based inactivation of aldose reductase by natural coumarins: molecular insights and experimental validation (2025-01-01)
        • GC-MS Profiling, Pharmacological Predictions, Molecular Docking, and ADME Studies of Different Parts of Thymus Linearis against Multiple Target Proteins in ... (2025-01-01)
        • Discovery of [1, 2, 4] Triazolo [1, 5-a] pyrimidine-Based Disruptors of the Skp2–Cks1 Protein–Protein Interaction through Integrated Computational and Experimental Analysis (2026-01-01)
        • Phenolic-based allosteric inhibition of PTP1B: unlocking new therapeutic potential for metabolic disorders (2025-01-01)
        • Targeting the TRIB3–MYC axis in cancer: mechanistic insights and therapeutic disruption strategies (2025-01-01)
        • Mechanism of Alkaloid-Based Inhibition of Aldose Reductase: Computational Perspectives and Experimental Validations (2025-01-01)
        • Beyond traditional medications: exploring novel and potential inhibitors of trypanothione reductase (LmTr) of Leishmania parasites (2025-01-01)
        • Natural product modulators of protein–protein interactions: A comprehensive review (2026-01-01)
        • Mechanistic insights into polyphenols-mediated squalene epoxidase inhibition: Computational models and experimental validation for targeting cholesterol biosynthesis (2025-01-01)
        • In silico assessment of a natural small molecule as an inhibitor of programmed death ligand 1 for cancer immunotherapy: a computational approach (2025-01-01)
        • Repurposing FDA-approved allosteric drugs as non-competitive inhibitors of human ugts: an integrated computational study and biochemical validation (2025-01-01)
        • Breaking the oncogenic link: BCL10–MALT1 disruption as a precision strike against NF-κB-driven lymphomas (2025-01-01)
        • Coumarin‐based allosteric inhibition of PTP1B: A potential strategy for metabolic regulation (2025-01-01)
        • Immunoinformatics and Biophysics Approaches to Design a Novel Multi-Epitope Vaccine Design against Staphylococcus auricularis (2022-01-01)
        • Disrupting the epigenetic alliance: structural insights and therapeutic strategies targeting DNMT1–UHRF1 (2025-01-01)
        • Modulating UDP-glucuronosyltransferase activity: Mechanisms, clinical implications, therapeutic strategies, and future directions in drug development (2025-01-01)
        • Sustainable leads for hypoxic tumor therapy: allosteric selective inhibition of carbonic anhydrase IX by abietane-type resin acids (2025-01-01)
        • 1H-Indazole-3-Carboxylic Acid Derivatives as Disruptors of the Oncogenic MTDH–SND1 Protein–Protein Interaction: An In Silico-to-In Vitro Study (2026-01-01)
        • Mechanism-based inhibition of squalene epoxidase by phenothiazines for lipid metabolism disruption using repurposed antipsychotic drugs (2025-01-01)
        • Disrupting the epigenetic alliance: Emerging strategies to disrupt the PRMT5: MEP50 complex for cancer therapy (2025-01-01)
        • CIB1 and platelet integrin αIIbβ3: Molecular mechanisms, disruption strategies, and antithrombotic opportunities (2025-01-01)
        • The role of diet and physical activity in preventing chronic diseases: a comprehensive review (2025-01-01)
        • Investigating the effects of four medicinal plants against dengue virus through QSAR modeling and molecular dynamics studies (2025-01-01)
        • Characterization of Helicobacter pylori immunoreactive proteins NusB, isoprenyl transferase, and hypothetical protein via immunoproteomics and molecular modeling approaches (2025-01-01)
        • Design of a Multi-Epitopes Based Chimeric Vaccine against Enterobacter cloacae Using Pan-Genome and Reverse Vaccinology Approaches. Vaccines (Basel). 2022; 10(6). Epub 2022 Jun 1 (2022-01-01)
        • CBFβ–SMMHC in inv (16) AML: Fusion Biology, RUNX1 Dysregulation, and Therapeutic Targeting of a Leukemogenic Protein–Protein Interaction (2026-01-01)
        • Terpenoid-based inhibition of sqle: Mechanistic computational and experimental insights into targeting cholesterol biosynthesis (2026-01-01)
        • Protein-protein interaction disruption as a next-generation antithrombotic strategy (2026-01-01)
        • Multi-scale In Silico and Biochemical Evaluation of Natural Bisbenzylisoquinoline Alkaloids as Aldose Reductase Inhibitors (2026-01-01)
        • Zingiberaceae-derived phytomolecules inhibit Japanese encephalitis virus RNA-dependent RNA polymerase: a molecular dynamics study (2025-01-01)
        • Structural and energetic analysis of NS5 protein inhibition by small molecules in Japanese encephalitis virus using machine learning and steered molecular dynamics approach (2025-01-01)
        • Entrance-channel plugging by natural sulfonamide antibiotics yields isoform-selective carbonic anhydrase IX inhibitors: an integrated in silico/in vitro discovery of … (2025-01-01)
        • Taming hyper-active Cdk5: disrupting the Cdk5–p25 axis as a therapeutic avenue for neurodegeneration and beyond (2025-01-01)
        • Mechanistic basis of aldose reductase inhibition by phenolics from Achillea fragrantissima: experimental insights and computational validation (2025-01-01)
        • Glucosinolate-Mediated Inhibition of Carbonic Anhydrase IX: A Study on Turnip (Brassica rapa) and its Potential in Cancer Prevention (2025-01-01)
        • Breaking the redox–calcium loop: Pharmacology, physiology and therapeutic promise of disrupting the endothelial TRPV4–NOX2 complex (2025-01-01)
        • Cheminformatics-enhanced discovery of therapeutic agents targeting isocitrate lyase in Mycobacterium tuberculosis infections (2025-01-01)
        • Tackling tumor hypoxia: advances in breaking the oncogenic HIF-1α–p300/CBP alliance (2025-01-01)
        • Advancing COVID-19 Treatment: The Role of Non-covalent Inhibitors Revealed by Integrated Machine Learning and Network Pharmacology (2025-01-01)
        • The CLOCK–BMAL1 complex in circadian regulation: structure, mechanisms, and therapeutic targeting (2026-01-01)
        • Discovery of 1H-Pyrrolo[2,3-b]pyridine-3-sulfonamides as disruptors of the oncogenic MTDH-SND1 Protein-Protein interaction through integrated in silico and in vitro screening (2026-01-01)
        • Structure-Guided Identification of 2-Arylbenzothiazole as disruptors for the Oncogenic MTDH–SND1 Protein–Protein Interaction (2026-01-01)
        • Disrupting the tumor-associated TNKS–USP25 protein–protein interface in cancer: structural basis, druggability, and therapeutic opportunities (2026-01-01)
        • Benzimidazole-2-carboxamide derivatives as small-molecule modulators of the thrombosis-related CIB1–integrin αIIb protein–protein interaction: computational and experimental … (2026-01-01)
        • Repurposing boswellic-acid derivatives as dual-site inhibitors of SQLE: biochemical and computational insights (2026-01-01)
        • Development of whey-protein–pullulan films loaded with Saussurea Costus latex phenolics as active packaging liners for shelf-life extension and gray-mold suppression in post … (2026-01-01)
        • Structure‐Based Discovery of N‐Aryl‐N′‐Heteroaryl Ureas as Disruptors of the Oncogenic MTDH–SND1 Protein–Protein Interaction: In Silico Insights and Biochemical Validation (2026-01-01)
        • Disrupting PQBP1–eEF2 protein-protein interaction: From synaptic translation to immunity and cancer (2026-01-01)
        • Disrupting the CBFβ-SMMHC-RUNX1 oncogenic protein–protein interaction in inv (16) AML: from fusion biology to targeted therapy (2026-01-01)
        • Recent advances in indole–thiazole hybrid scaffolds: synthesis, molecular hybridization, and pharmacological potential (2026-01-01)
        • Targeting the Elongin BC–BC-Box Interface: Structural Insights, Peptidic Disruptors, and Emerging Small-Molecule Strategies (2026-01-01)
        • Disrupting the KRAS–SOS1 protein–protein interaction: mechanistic rationale for pan-KRAS pathway suppression and combination therapy (2026-01-01)
        • Disrupting E3 ubiquitin ligase protein–protein interactions in cancer: chemical modalities, mechanisms, and therapeutic opportunities (2026-01-01)
        • Disarming the Hsp70–Bim Alliance: Small-Molecule and Peptidic Disruptors of a Chaperone-Apoptotic Switch in Cancer (2026-01-01)
        • Design and Validation of a Polyunit Epitope Vaccine Against Enterococcus faecium (2026-01-01)
        • Disrupting the ASH2L–DPY30 PPI in cancer: structure, function, and therapeutic opportunities in H3K4 methylation (2026-01-01)
        • Disrupting the USP1–UAF1 deubiquitinase complex: a master regulator of replication stress and a frontier target in cancer therapy (2026-01-01)
        • Repurposing Ammi visnaga Furanocoumarins as Potent Squalene Epoxidase Inhibitors to Disrupt Lipid Metabolism: An Integrated Phytochemical, In Vitro, and In... (2025-01-01)
        • Repurposing Fagonia Indica Alkaloids as Allosteric PTP 1B Inhibitors: Computational Profiling and Biochemical Validation (2025-01-01)
        • Mechanism-Based Allosteric Inhibition of PTP1B by Prenylated Flavonoids from Glycyrrhiza echinata: In Vitro Experiments and in Silico Validation (2025-01-01)
        • Community-based physical activity interventions for the prevention of lifestyle diseases in low-income populations: a systematic review (2025-01-01)
        • A Multidisciplinary Approach to Targeting PTP1B Inhibition Mechanisms in Metabolic Disorders Using Flavonoids From Scutellaria Salviifolia: An Integrative In Vitro … (2025-01-01)
        • Advancements in the Structural Basis of Covalent Inhibitors Targeting Essential SARS-CoV-2 Proteins (2025-01-01)
        • ELUCIDATING THE POTENTIAL OF DIETARY PUFAs (Ω-3) IN TACKLING CYTOKINE STORM SYNDROME BY ATENUATING PRO-INFLAMMATORY CYTOKINES (2025-01-01)
        • Disrupting the CCND1–CDK4 Protein-Protein Interaction: Emerging Strategies to Target Cyclin D–Dependent Kinase Assembly in Cancer (2026-01-01)
        • Oxygenated 9H-carbazole-3-carbaldehyde scaffolds as cerebral cavernous malformation-relevant protein–protein interaction disruptors of the HEG1–KRIT1 interface (2026-01-01)
        • Structure-guided delineation of umbelliferyl phosphate-based disruptors of the c-Myb–CBP/p300 KIX protein–protein interaction (2026-01-01)
        • Natural Product Modulators of Protein-Protein Interactions: A Comprehensive Review (2026-02-12)
        • Physical Therapists' Self-Reported Perceptions of Bedside Manners in Saudi Arabia: A Mixed-Methods Study (2026-07-23)
        • Structure-based discovery of diphenylpyrazines as disruptors of the Skp2–Cks1 protein–protein interaction: computational insights and biochemical validation (2026-01-01)
        • Targeting the c-Myb–CBP/p300 KIX Protein–Protein Interaction with Quinone-Methide Triterpenes: In silico Mechanistic insights and MST Biochemical Validation (2026-01-01)
        • Structure-Based Discovery of Fumiquinazolines as Skp2–Cks1 Protein–Protein Interaction Disruptors: Mechanistic Computational Insights and Experimental Validation (2026-01-01)
        • Advancing COVID-19 Treatment: The Role of Non-covalent Inhibitors Revealed by Integrated Machine Learning and Network Pharmacology (2025-01-01)
        • Mechanistic Insights into Alkaloid-Based Inhibition of Squalene Epoxidase: A Combined In Silico and Experimental Approach for Targeting Cholesterol Biosynthesis (2025-02-06)
        • Tackling tumor hypoxia: advances in breaking the oncogenic HIF-1α-p300/CBP alliance (2025-08-21)
        • Targeting the TRIB3-MYC axis in cancer: mechanistic insights and therapeutic disruption strategies (2025-09-04)
        • Mechanistic Insights into Polyphenol-Mediated Squalene Epoxidase Inhibition: Computational Models and Experimental Validation for Targeting Cholesterol Biosynthesis (2025-05-26)
        • Repurposing Fagonia indica Alkaloids as Allosteric PTP 1B Inhibitors: Computational Profiling and Biochemical Validation (2025-08-22)
        • Breaking the oncogenic link: BCL10-MALT1 disruption as a precision strike against NF-κB-driven lymphomas (2025-07-19)
        • Cannabinoids in neuropathic pain treatment: pharmacological insights and clinical outcomes from recent trials (2025-04-22)
        • Repurposing Ammi visnaga Furanocoumarins as Potent Squalene Epoxidase Inhibitors to Disrupt Lipid Metabolism: An Integrated Phytochemical, In Vitro, and In Silico Study (2025-12-10)
        • Glucosinolate-Mediated Inhibition of Carbonic Anhydrase IX: A Study on Turnip (Brassica rapa) and Its Potential in Cancer Prevention (2025-06-27)
        • Comprehensive insights into carbonic anhydrase inhibition: A triad of in vitro, in silico, and in vivo perspectives (2025-04-18)
        • Modulating UDP-glucuronosyltransferase activity: Mechanisms, clinical implications, therapeutic strategies, and future directions in drug development (2025-10-25)
        • β-Glucuronidase Inhibition in Drug Development: Emerging Strategies for Mitigating Drug-Induced Toxicity and Enhancing Therapeutic Outcomes (2025-06-16)
        • Disarming the Hsp70-Bim Alliance: Small-Molecule and Peptidic Disruptors of a Chaperone-Apoptotic Switch in Cancer (2025-12-12)
        • Inhibitory Mechanisms of β-Glucuronidase by Phenolic Compounds from Hibiscus syriacus: Integrating Computational and Experimental Approaches (2025-01-03)
        • A Multidisciplinary Approach to Targeting PTP1B Inhibition Mechanisms in Metabolic Disorders Using Flavonoids From Scutellaria salviifolia: An Integrative In Vitro and In Silico Analysis (2025-06-06)
        • Disrupting the epigenetic alliance: structural insights and therapeutic strategies targeting DNMT1-UHRF1 (2025-09-17)
        • Phenolic-based allosteric inhibition of PTP1B: unlocking new therapeutic potential for metabolic disorders (2025-06-24)
        • Mechanism-Based Allosteric Inhibition of PTP1B by Prenylated Flavonoids from Glycyrrhiza echinata: In Vitro Experiments and In Silico Validation (2025-07-16)
        • Multi-scale In Silico and Biochemical Evaluation of Natural Bisbenzylisoquinoline Alkaloids as Aldose Reductase Inhibitors (2025-11-08)
        • Multi-pronged approaches to the mechanism-based inactivation of aldose reductase by natural coumarins: molecular insights and experimental validation (2025-05-15)
        • Mechanistic Basis of Aldose Reductase Inhibition by Phenolics from Achillea fragrantissima: Experimental Insights and Computational Validation (2025-08-24)
        • Mechanism of Alkaloid-Based Inhibition of Aldose Reductase: Computational Perspectives and Experimental Validations (2025-07-11)
        • Dismantling the epigenetic alliance: Emerging strategies to disrupt the PRMT5:MEP50 complex for cancer therapy (2025-06-17)
        • Uncoupling toxic NO signaling: Progress, challenges, and therapeutic promise of disrupting the PSD-95/nNOS protein-protein interaction (2025-07-24)
        • Targeting the Skp2-Cks1 protein-protein interaction: structures, assays, and preclinical inhibitors (2025-09-09)
        • Repurposing Dual-C-Prenylated Flavonoids as Potent Allosteric Inhibitors of PTP1B: Integrated Phytochemical, Enzymological, and In Silico Evidence (2025-05-30)
        • Breaking the redox-calcium loop: Pharmacology, physiology, and therapeutic promise of disrupting the endothelial TRPV4-NOX2 complex (2025-09-01)
        • Mechanism-based inhibition of aldose reductase by natural xanthones: Computational and experimental insights for diabetic complications (2025-04-26)
        • Targeting the ATG12-ATG3 protein-protein interaction: From structural insights to therapeutic opportunities in autophagy modulation (2025-08-04)
        • Taming hyper-active Cdk5: Disrupting the Cdk5-p25 axis as a therapeutic avenue for neurodegeneration and beyond (2025-09-17)
        • Repurposing FDA-approved allosteric drugs as non-competitive inhibitors of human UGTs: An integrated computational study and biochemical validation (2025-06-14)
        • CIB1 and platelet integrin αIIbβ3: Molecular mechanisms, disruption strategies, and antithrombotic opportunities (2025-09-09)
        • Mycosynthesis of zinc oxide nanoparticles using Mucor racemosus and their antimicrobial, antibiofilm, anticancer, and antioxidant activities (2025-05-29)
        • Mechanism-based inhibition of squalene epoxidase by phenothiazines for lipid metabolism disruption using repurposed antipsychotic drugs (2025-10-15)
        • Disrupting the Hsp90-Cdc37 axis: a selective strategy for targeting oncogenic kinases in cancer (2025-06-04)
        • Breaking the oncogenic alliance: advances in disrupting the MTDH-SND1 complex for cancer therapy (2025-08-22)
        • Sustainable leads for hypoxic tumor therapy: allosteric selective inhibition of carbonic anhydrase IX by abietane-type resin acids (2025-08-18)
        • In vitro and in silico mechanistic insights into PTP1B inhibition by sulfated flavonoids from Flaveria bidentis (2025-04-28)
        • Multidimensional Insights into Squalene Epoxidase Drug Development: In Vitro Mechanisms, In Silico Modeling, and In Vivo Implications (2025-05-09)
        • Terpenoid-Based Inhibition of SQLE: Mechanistic Computational and Experimental Insights into Targeting Cholesterol Biosynthesis (2025-06-19)
        • Watercress-derived glucosinolates as potential allosteric PTP1B inhibitors: a dual in silico and in vitro study on insulin signaling modulation (2025-06-19)
        • Entrance-channel plugging by natural sulfonamide antibiotics yields isoform-selective carbonic anhydrase IX inhibitors: an integrated in silico/in vitro discovery of the lead compound SB-203207 (2025-09-23)
        • Advancements in the Structural Basis of Covalent Inhibitors Targeting Essential SARS-CoV-2 Proteins (2025-01-01)
        • Elucidating Potential of Dietary PUFAs (Ω-3) In Tackling Cytokine Storm Syndrome by Attenuation of Pro-Inflammatory Cytokines (2025-01-01)
        • GC-MS Profiling, Pharmacological Predictions, Molecular Docking, and ADME Studies of Different Parts of Thymus Linearis Against Multiple Target Proteins in Wound Healing (2024-11-12)
        • Unraveling the Mechanism of Carbonic Anhydrase IX Inhibition by Alkaloids from Ruta chalepensis: A Synergistic Analysis of In Vitro and In Silico Data (2024-09-13)
        • Bridging in silico and in vitro perspectives to unravel molecular mechanisms underlying the inhibition of β-glucuronidase by coumarins from Hibiscus trionum (2024-07-29)
        • Multifaceted role of synbiotics as nutraceuticals, therapeutics, and carriers for drug delivery (2022-10-26)
        • The effect of krill oil supplementation on skeletal muscle function and size in older adults: A randomized controlled trial (2022-04-30)
        • Novel drug discovery: Advancing Alzheimer's therapy through machine learning and network pharmacology (2024-05-27)
        • Dynamic interactions and inhibitory mechanisms of Artemisia annua terpenoids with carbonic anhydrase IX (2024-11-02)
        • Characterization of Helicobacter pylori immunoreactive proteins NusB, isoprenyl transferase, and hypothetical protein via immunoproteomics and molecular modeling approaches (2024-12-28)
        • A microemulsion-based gel of isotretinoin and erythromycin estolate for the management of acne (2022-03-24)
        • Expanding arsenal against diabetic wounds using nanomedicines and nanomaterials: Success so far and bottlenecks (2022-06-30)
        • An overview of biomedical applications for gold nanoparticles against lung cancer (2023-07-06)
        • An in silico hierarchical approach for the discovery and validation of drug candidates—natural product inhibitors—against the pyrimidine biosynthesis enzyme in antibiotic-resistant Shigella flexneri (2022-02-01)
        • Sulfaquinoxaline-derived Schiff bases: Synthesis, characterization, biological profiling, and computational modeling (2024-10-11)
        • Mechanistic insights into β-glucuronidase inhibition by isoprenylated flavonoids from Centaurea scoparia: Bridging experimental and computational approaches (2024-10-13)
        • Kaempferitrin inhibits colorectal cancer cells by inducing reactive oxygen species and modulating the PI3K/AKT signaling pathway. (2022-03-06)
        • Harnessing unexplored medicinal values of the red-listed South African weed *Erigeron bonariensis*: From ethnobotany to biomedicine (2023-07-27)
        • Muscle protein synthesis and muscle/metabolic responses to resistance exercise training in South Asian and White European men (2022-02-15)
        • Discovery of Rift Valley fever virus natural pan-inhibitors by targeting its multiple key proteins through computational approaches (2022-06-03)
        • Unraveling the Molecular Mechanisms of β-Glucuronidase Inhibition by Flavonoids from Centaurea scoparia: Integrated In Silico and In Vitro Insights (2024-07-26)
        • Beyond traditional medications: exploring novel and potential inhibitors of trypanothione reductase (LmTr) of Leishmania parasites (2023-12-27)
        • Investigating the effects of four medicinal plants against dengue virus through QSAR modeling and molecular dynamics studies (2024-01-03)
        • Structural and energetic analysis of NS5 protein inhibition by small molecules in Japanese encephalitis virus using machine learning and steered molecular dynamics approach (2024-02-12)
        • In silico Assessment of a Natural Small Molecule as an Inhibitor of Programmed Death Ligand 1 for Cancer Immunotherapy: A Computational Approach (2024-02-12)
        • Zingiberaceae-derived phytomolecules inhibit Japanese encephalitis virus RNA-dependent RNA polymerase: a molecular dynamics study (2024-02-29)
        • Cheminformatics-Enhanced Discovery of Therapeutic Agents Targeting Isocitrate Lyase in Mycobacterium tuberculosis Infections (2024-09-12)
        • Garlic extract alleviates trastuzumab-induced hepatotoxicity in rats through its antioxidant, anti-inflammatory, and antihyperlipidemic effects (2021-01-01)
        • Recent Development of Zolmitriptan Formulation in Migraine Therapy: Production, Metabolism and Pharmaceutical Aspects (2024-09-13)
        • Discovery of Novel Inhibitors from Medicinal Plants for V-Domain Ig Suppressor of T-Cell Activation (2021-10-26)
        • Insights into the Binding of Receptor-Binding Domain (RBD) of SARS-CoV-2 Wild Type and B.1.620 Variant with hACE2 Using Molecular Docking and Simulation Approaches (2021-12-01)
        • Core Proteomics-Based Annotation of Antigenic Targets and Reverse Vaccinology-Assisted Design of an Ensemble Immunogen Against the Emerging Nosocomial Infection-Causing Bacterium Elizabethkingia meningoseptica (2022-01-01)
        • Prospective Role of Bioactive Molecules and Exosomes in the Therapeutic Potential of Camel Milk Against Human Diseases: An Updated Perspective (2022-07-01)
        • Immunoinformatics and Biophysics Approaches to the Design of a Novel Multi-Epitope Vaccine against Staphylococcus auricularis (2022-05-01)
        • Design of a Multi-Epitope-Based Chimeric Vaccine Against Enterobacter cloacae Using Pan-Genome and Reverse Vaccinology Approaches (2022-06-01)
        • 1H-Indazole-3-Carboxylic Acid Derivatives as Disruptors of the Oncogenic MTDH-SND1 Protein-Protein Interaction: An In Silico-to-In Vitro Study (2026-05-28)
        • Protein-protein interaction disruption as a next-generation antithrombotic strategy (2026-05-18)
        • Disrupting the CBFβ-SMMHC-RUNX1 oncogenic protein-protein interaction in inv(16) AML: from fusion biology to targeted therapy (2026-05-16)
        • Recent advances in indole-thiazole hybrid scaffolds: synthesis, molecular hybridization, and pharmacological potential (2026-05-08)
        • Disrupting PQBP1-eEF2 Protein-Protein Interaction: From Synaptic Translation to Immunity and Cancer (2026-04-15)
        • Disrupting the KRAS-SOS1 protein-protein interaction: mechanistic rationale for pan-KRAS pathway suppression and combination therapy (2026-04-07)
        • Disrupting E3 ubiquitin ligase protein-protein interactions in cancer: chemical modalities, mechanisms, and therapeutic opportunities (2026-08-01)
        • Disrupting the ASH2L-DPY30 PPI in cancer: structure, function, and therapeutic opportunities in H3K4 methylation (2026-03-21)
        • Benzimidazole-2-carboxamide derivatives as small-molecule modulators of the thrombosis-related CIB1-integrin αIIb protein-protein interaction: computational and experimental insights (2026-06-29)
        • Development of whey protein-pullulan films loaded with phenolic compounds from Saussurea costus latex as active packaging liners to extend shelf life and suppress gray mold in post-harvest cherry tomatoes (2026-06-04)
        • The CLOCK-BMAL1 complex in circadian regulation: structure, mechanisms, and therapeutic targeting (2026-05-26)
        • Targeting the Elongin BC-BC-Box Interface: Structural Insights, Peptidic Disruptors, and Emerging Small-Molecule Strategies (2026-05-03)
        • Discovery of [1,2,4]triazolo[1,5-a]pyrimidine-based disruptors of the Skp2-Cks1 protein-protein interaction through integrated computational and experimental analysis (2026-06-18)
        • Disrupting the USP1-UAF1 deubiquitinase complex: a master regulator of replication stress and frontier target in cancer therapy (2026-03-09)
        • Coumarin-Based Allosteric Inhibition of PTP1B: A Potential Strategy for Metabolic Regulation (2025-05-01)
        • Design and Validation of a Polyunit Epitope Vaccine Against Enterococcus faecium (2025-05-30)
        • The impact of time of day on metabolic responses to exercise in adults: A systematic and meta-analysis review (2024-10-24)
        • Advances in Designing Polymeric Micelles for Biomedical Applications in Brain-Related Diseases (2022-05-11)
        • The effect of short-duration resistance training on insulin sensitivity and muscle adaptations in overweight men (2019-04-01)
        • CBFβ-SMMHC in inv(16) AML: Fusion biology, RUNX1 dysregulation, and therapeutic targeting of a leukemogenic protein-protein interaction (2026-07-02)
        • Disrupting the tumor-associated TNKS-USP25 protein-protein interface in cancer: structural basis, druggability, and therapeutic opportunities (2026-07-06)
        • Discovery of 1H-Pyrrolo[2,3-b]pyridine-3-sulfonamides as disruptors of the oncogenic MTDH-SND1 Protein-Protein interaction through integrated in silico and in vitro screening (2026-07-30)
        • Structure-guided identification of 2-arylbenzothiazoles as disruptors of the oncogenic MTDH-SND1 protein-protein interaction (2026-07-25)
        • Structure-Based Discovery of N-Aryl-N′-Heteroaryl Ureas as Disruptors of the Oncogenic MTDH-SND1 Protein-Protein Interaction: In Silico Insights and Biochemical Validation (2026-06-01)
        • Oxygenated 9H-carbazole-3-carbaldehyde scaffolds as cerebral cavernous malformation-relevant protein-protein interaction disruptors of the HEG1-KRIT1 interface (2026-08-18)
        • Thyme oil alleviates Ova-induced bronchial asthma through modulating Th2 cytokines, IgE, TSLP and ROS (2021-06-08)
        • Structure-guided delineation of umbelliferyl phosphate-based disruptors of the c-Myb-CBP/p300 KIX protein-protein interaction (2026-08-23)
        • Structure-Based Discovery of Fumiquinazolines as Skp2-Cks1 Protein-Protein Interaction Disruptors: Mechanistic Computational Insights and Experimental Validation (2026-08-28)
        • Structure-based discovery of diphenylpyrazines as disruptors of the Skp2-Cks1 protein-protein interaction: computational insights and biochemical validation (2026-08-27)
        • Repurposing boswellic-acid derivatives as dual-site inhibitors of SALE: biochemical and computational insights (2026-09-01)
        • Targeting the c-Myb-CBP/p300 KIX protein-protein interaction with quinone-methide triterpenes: In silico mechanistic insights and MST biochemical validation (2026-08-28)
        • Terpenoid-Based Inhibition of SQLE: Mechanistic Computational and Experimental Insights into Targeting Cholesterol Biosynthesis (2026-06-01)
        • Targeting the Elongin BC–BC-Box Interface: Structural Insights, Peptidic Disruptors, and Emerging Small-Molecule Strategies (2026-05-01)
        • Disrupting the USP1–UAF1 deubiquitinase complex: a master regulator of replication stress and a frontier target in cancer therapy (2026-04-01)
        • Natural Product Modulators of Protein–Protein Interactions: A Comprehensive Review (2026-04-01)
        • Disarming the Hsp70–Bim Alliance: Small-Molecule and Peptidic Disruptors of a Chaperone-Apoptotic Switch in Cancer (2026-04-01)
        • Design and Validation of a Polyunit Epitope Vaccine Against Enterococcus faecium (2026-03-01)
        • Repurposing Boswellic Acid Derivatives as Dual-Site Inhibitors of SQLE: Biochemical and Computational Insights (2026-02-19)
        • Multi-scale In Silico and Biochemical Evaluation of Natural Bisbenzylisoquinoline Alkaloids as Aldose Reductase Inhibitors (2026-02-01)
        • Discovery of 1 H-Pyrrolo[2,3-b]pyridine-3-sulfonamides as disruptors of the oncogenic MTDH-SND1 Protein-Protein interaction through integrated in silico and in vitro screening (2026-01-01)
        • Benzimidazole-2-carboxamide derivatives as small-molecule modulators of the thrombosis-related CIB1–integrin αIIb protein–protein interaction: computational and experimental insights (2026-01-01)
        • Disrupting the KRAS–SOS1 protein–protein interaction: mechanistic rationale for pan-KRAS pathway suppression and combination therapy (2026-01-01)
        • Protein-protein interaction disruption as a next-generation antithrombotic strategy (2026-01-01)
        • Mechanism-based inhibition of squalene epoxidase by phenothiazines for lipid metabolism disruption using repurposed antipsychotic drugs (2025-12-01)
        • The entry-channel blocking by natural sulfonamide antibiotics yields isoform-selective carbonic anhydrase IX inhibitors: an integrated in silico/in vitro discovery of the lead SB-203207 (2025-12-01)
        • Disrupting the epigenetic alliance: structural insights and therapeutic strategies targeting DNMT1–UHRF1 (2025-12-01)
        • Repurposing Fagonia Indica Alkaloids as Allosteric PTP 1B Inhibitors: Computational Profiling and Biochemical Validation (2025-12-01)
        • Phenolic-based allosteric inhibition of PTP1B: unlocking new therapeutic potential for metabolic disorders (2025-12-01)
        • Watercress-derived glucosinolates as potential allosteric PTP1B inhibitors: a dual in silico and in vitro study on insulin signaling modulation (2025-12-01)
        • Mycosynthesis of zinc oxide nanoparticles using Mucor racemosus with their antimicrobial, antibiofilm, anticancer and antioxidant activities (2025-12-01)
        • Mechanistic Insights into Polyphenol-Mediated Squalene Epoxidase Inhibition: Computational Models and Experimental Validation for Targeting Cholesterol Biosynthesis (2025-12-01)
        • Uncoupling toxic NO signaling: Progress, challenges, and therapeutic promise of disrupting the PSD-95/nNOS protein–protein interaction (2025-11-15)
        • Targeting the Skp2–Cks1 protein–protein interaction: structures, assays, and preclinical inhibitors (2025-11-05)
        • Breaking the redox–calcium loop: Pharmacology, physiology and therapeutic promise of disrupting the endothelial TRPV4–NOX2 complex (2025-11-01)
        • Dismantling the epigenetic alliance: Emerging strategies to disrupt the PRMT5:MEP50 complex for cancer therapy (2025-10-15)
        • CIB1 and platelet integrin αIIbβ3: Molecular mechanisms, disruption strategies, and antithrombotic opportunities (2025-10-01)
        • Mechanism-Based Allosteric Inhibition of PTP1B by Prenylated Flavonoids from Glycyrrhiza echinata: In Vitro Experiments and in Silico Validation (2025-10-01)
        • Modulating UDP-glucuronosyltransferase activity: Mechanisms, clinical implications, therapeutic strategies, and future directions in drug development (2025-10-01)
        • Cannabinoids in neuropathic pain treatment: pharmacological insights and clinical outcomes from recent trials (2025-10-01)
        • Targeting the ATG12-ATG3 protein-protein interaction: From structural insights to therapeutic opportunities in autophagy modulation (2025-09-01)
        • Mechanistic basis of aldose reductase inhibition by phenolics from Achillea fragrantissima: experimental insights and computational validation (2025-09-01)
        • Glucosinolate-Mediated Inhibition of Carbonic Anhydrase IX: A Study on Turnip (Brassica rapa) and its Potential in Cancer Prevention (2025-09-01)
        • Repurposing FDA-approved allosteric drugs as non-competitive inhibitors of human UGTs: An integrated computational study and biochemical validation (2025-09-01)
        • Comprehensive insights into carbonic anhydrase inhibition: A triad of in vitro, in silico, and in vivo perspectives (2025-09-01)
        • Breaking the oncogenic alliance: advances in disrupting the MTDH-SND1 complex for cancer therapy (2025-08-22)
        • Sustainable leads for hypoxic tumor therapy: allosteric selective inhibition of carbonic anhydrase IX by abietane-type resin acids (2025-08-18)
        • Targeting the TRIB3–MYC axis in cancer: mechanistic insights and therapeutic disruption strategies (2025-08-01)
        • Tackling tumor hypoxia: advances in breaking the oncogenic HIF-1α–p300/CBP alliance (2025-08-01)
        • Breaking the oncogenic link: BCL10–MALT1 disruption as a precision strike against NF-κB-driven lymphomas (2025-08-01)
        • Mechanism of Alkaloid-Based Inhibition of Aldose Reductase: Computational Perspectives and Experimental Validations (2025-08-01)
        • Mechanism-based inhibition of aldose reductase by natural xanthones: Computational and experimental insights for diabetic complications (2025-07-01)
        • A Multidisciplinary Approach to Targeting PTP1B Inhibition Mechanisms in Metabolic Disorders Using Flavonoids from Scutellaria Salviifolia: An Integrative In Vitro and In Silico Analysis (2025-06-11)
        • Disrupting the Hsp90-Cdc37 axis: a selective strategy for targeting oncogenic kinases in cancer (2025-06-09)
        • β-Glucuronidase Inhibition in Drug Development: Emerging Strategies for Mitigating Drug-Induced Toxicity and Enhancing Therapeutic Outcomes (2025-06-01)
        • Repurposing dual-C-prenylated flavonoids as potent allosteric inhibitors of PTP1B: Integrated phytochemical, enzymological, and in silico evidence (2025-06-01)
        • Multi-pronged approaches to the mechanism-based inactivation of aldose reductase by natural coumarins: molecular insights and experimental validation (2025-06-01)
        • Coumarin-Based Allosteric Inhibition of PTP1B: A Potential Strategy for Metabolic Regulation (2025-05-01)
        • Mechanistic insights into alkaloid-based inhibition of squalene epoxidase: A combined in silico and experimental approach for targeting cholesterol biosynthesis (2025-04-01)
        • Mechanistic insights into β-glucuronidase inhibition by isoprenylated flavonoids from Centaurea scoparia: Bridging experimental and computational approaches (2025-02-15)
        • Sulfaquinoxaline-derived Schiff bases: Synthesis, characterization, biological profiling, and computational modeling (2025-02-05)
        • Characterization of Helicobacter pylori immunoreactive proteins NusB, isoprenyl transferase, and hypothetical protein via immunoproteomics and molecular modeling approaches (2025-02-01)
        • GC-MS Profiling, Pharmacological Predictions, Molecular Docking, and ADME Studies of Different Parts of Thymus Linearis against Multiple Target Proteins in Wound Healing (2025-02-01)
        • Inhibitory Mechanisms of β-Glucuronidase by Hibiscus syriacus Phenolics: Integrating Computational and Experimental Approaches (2025-01-08)
        • Elucidating Potential of Dietary PUFAs (Ω-3) In Tackling Cytokine Storm Syndrome by Attenuation of Pro-Inflammatory Cytokines (2025-01-01)
        • Cheminformatics-enhanced discovery of therapeutic agents targeting isocitrate lyase in Mycobacterium tuberculosis infections (2025-01-01)
        • Zingiberaceae-derived phytomolecules inhibit Japanese encephalitis virus RNA-dependent RNA polymerase: a molecular dynamics study (2025-01-01)
        • In silico assessment of a natural small molecule as an inhibitor of programmed death ligand 1 for cancer immunotherapy: a computational approach (2025-01-01)
        • Structural and energetic analysis of NS5 protein inhibition by small molecules in Japanese encephalitis virus using machine learning and steered molecular dynamics approach (2025-01-01)
        • Investigating the effects of four medicinal plants against dengue virus through QSAR modeling and molecular dynamics studies (2025-01-01)
        • Beyond traditional medications: exploring novel and potential inhibitors of trypanothione reductase (LmTr) of Leishmania parasites (2025-01-01)
        • Advancements in the Structural Basis of Covalent Inhibitors Targeting Essential SARS-CoV-2 Proteins (2025-01-01)
        • Multidimensional insights into squalene epoxidase drug development: in vitro mechanisms, in silico modeling, and in vivo implications (2025-01-01)
        • Advancing COVID-19 Treatment: The Role of Non-covalent Inhibitors Revealed by Integrated Machine Learning and Network Pharmacology (2025-01-01)
        • In vitro and In silico mechanistic insights into PTP1B inhibition by sulfated flavonoids from Flaveria bidentis (2025-01-01)
        • Dynamic interactions and inhibitory mechanisms of Artemisia annua terpenoids with carbonic anhydrase IX (2024-12-01)
        • Unraveling the mechanism of carbonic anhydrase IX inhibition by alkaloids from Ruta chalepensis: A synergistic analysis of in vitro and in silico data (2024-11-12)
        • Bridging in silico and in vitro perspectives to unravel molecular mechanisms underlying the inhibition of β-glucuronidase by coumarins from Hibiscus trionum (2024-10-01)
        • Dissecting molecular mechanisms underlying the inhibition of β-glucuronidase by alkaloids from Hibiscus trionum: Integrating in vitro and in silico perspectives (2024-09-01)
        • Novel drug discovery: Advancing Alzheimer's therapy through machine learning and network pharmacology (2024-08-05)
        • Unraveling molecular mechanisms of β-glucuronidase inhibition by flavonoids from Centaurea scoparia: integrated in silico and in vitro insights (2024-07-26)
        • Structure-based discovery of diphenylpyrazines as disruptors of the Skp2–Cks1 protein–protein interaction: computational insights and biochemical validation (2026-12-01)
        • Structure-guided delineation of umbelliferyl phosphate-based disruptors of the c-Myb–CBP/p300 KIX protein–protein interaction (2026-12-01)
        • Oxygenated 9H-carbazole-3-carbaldehyde scaffolds as cerebral cavernous malformation-relevant protein–protein interaction disruptors of the HEG1–KRIT1 interface (2026-12-01)
        • The CLOCK–BMAL1 complex in circadian regulation: structure, mechanisms, and therapeutic targeting (2026-12-01)
        • Disrupting the CBFβ-SMMHC-RUNX1 oncogenic protein–protein interaction in inv(16) AML: from fusion biology to targeted therapy (2026-12-01)
        • Disrupting the ASH2L–DPY30 PPI in cancer: structure, function, and therapeutic opportunities in H3K4 methylation (2026-12-01)
        • Targeting the c-Myb–CBP/p300 KIX protein–protein interaction with quinone-methide triterpenes: In silico mechanistic insights and MST biochemical validation (2026-11-01)
        • Structure-guided identification of 2-arylbenzothiazoles as disruptors of the oncogenic MTDH–SND1 protein–protein interaction (2026-10-01)
        • Structure-Based Discovery of Fumiquinazolines as Skp2–Cks1 Protein–Protein Interaction Disruptors: Mechanistic Computational Insights and Experimental Validation (2026-09-14)
        • 1H-Indazole-3-Carboxylic Acid Derivatives as Disruptors of the Oncogenic MTDH–SND1 Protein–Protein Interaction: An In Silico-to-In Vitro Study (2026-09-01)
        • Disrupting E3 ubiquitin ligase protein–protein interactions in cancer: chemical modalities, mechanisms, and therapeutic opportunities (2026-08-01)
        • Disrupting the tumor-associated TNKS–USP25 protein–protein interface in cancer: structural basis, druggability, and therapeutic opportunities (2026-07-06)
        • Development of whey-protein-pullulan films loaded with Saussurea Costus latex phenolics as active packaging liners for shelf-life extension and gray-mold suppression in post-harvest cherry tomatoes (2026-07-01)
        • Discovery of [1,2,4]triazolo[1,5-a]pyrimidine-based disruptors of the Skp2–Cks1 protein–protein interaction through integrated computational and experimental analysis (2026-06-18)
        • Structure-Based Discovery of N-Aryl-N′-Heteroaryl Ureas as Disruptors of the Oncogenic MTDH–SND1 Protein–Protein Interaction: In Silico Insights and Biochemical Validation (2026-06-01)
        • Recent advances in indole–thiazole hybrid scaffolds: synthesis, molecular hybridization, and pharmacological potential (2026-06-01)
        • Disrupting PQBP1–eEF2 protein-protein interaction: From synaptic translation to immunity and cancer (2026-06-01)
        • Repurposing Ammi visnaga Furanocoumarins as Potent Squalene Epoxidase Inhibitors to Disrupt Lipid Metabolism: An Integrated Phytochemical, In Vitro, and In Silico Study (2026-06-01)
        • Recent Development of Zolmitriptan Formulation in Migraine Therapy: Production, Metabolism and Pharmaceutical Aspects (2024-01-01)
        • The impact of time of day on metabolic responses to exercise in adults: A systematic and meta-analysis review (2024-01-01)
        • Harnessing unexplored medicinal values of the red-listed South African weed *Erigeron bonariensis*: From ethnobotany to biomedicine (2023-09-01)
        • An overview of biomedical applications for gold nanoparticles against lung cancer (2023-09-01)
        • Multifaceted role of synbiotics as nutraceuticals, therapeutics, and carriers for drug delivery (2022-12-01)
        • Discovery of Rift Valley fever virus natural pan-inhibitors by targeting its multiple key proteins through computational approaches (2022-12-01)
        • Muscle protein synthesis and muscle/metabolic responses to resistance exercise training in South Asian and White European men (2022-12-01)
        • Expanding arsenal against diabetic wounds using nanomedicines and nanomaterials: Success so far and bottlenecks (2022-08-01)
        • Prospective Role of Bioactive Molecules and Exosomes in the Therapeutic Potential of Camel Milk Against Human Diseases: An Updated Perspective (2022-07-01)
        • Advances in Designing Polymeric Micelles for Biomedical Applications in Brain-Related Diseases (2022-07-01)
        • Design of a Multi-Epitope-Based Chimeric Vaccine against Enterobacter cloacae Using Pan-Genome and Reverse Vaccinology Approaches (2022-06-01)
        • The effect of krill oil supplementation on skeletal muscle function and size in older adults: A randomized controlled trial (2022-06-01)
        • Immunoinformatics and Biophysics Approaches to Design a Novel Multi-Epitope Vaccine Design against Staphylococcus auricularis (2022-05-01)
        • A microemulsion-based gel of isotretinoin and erythromycin estolate for the management of acne (2022-05-01)
        • Kaempferitrin inhibits colorectal cancer cells by inducing reactive oxygen species and modulating the PI3K/AKT signaling pathway. (2022-05-01)
        • An in silico hierarchical approach for drug candidate mining and validation of natural product inhibitors against pyrimidine biosynthesis enzyme in the antibiotic-resistant Shigella flexneri (2022-03-01)
        • Annotation of antigenic targets based on core proteomics and reverse-vaccinology-assisted design of an ensemble immunogen against the emerging nosocomial infection-causing bacterium Elizabethkingia meningoseptica (2022-01-01)
        • Insights into the binding of receptor-binding domain (Rbd) of sars-cov-2 wild type and b.1.620 variant with hace2 using molecular docking and simulation approaches (2021-12-01)
        • Discovery of Novel Inhibitors from Medicinal Plants for V-Domain Ig Suppressor of T-Cell Activation (2021-10-26)
        • Thyme oil alleviates Ova-induced bronchial asthma through modulating Th2 cytokines, IgE, TSLP and ROS (2021-08-01)
        • Garlic extract alleviates trastuzumab-induced hepatotoxicity in rats through its antioxidant, anti-inflammatory, and antihyperlipidemic effects (2021-01-01)
        • The effect of short-duration resistance training on insulin sensitivity and muscle adaptations in overweight men (2019-04-01)
        • Structural discovery of acridone alkaloids as disruptors of the HEG1–KRIT1 protein–protein interaction in cerebral cavernous malformation signaling (2026-01-01)
        • Structural discovery of acridone alkaloids as disruptors of the HEG1–KRIT1 protein–protein interaction in cerebral cavernous malformation signaling (2026-01-01)
        • Integrated computational and biochemical identification of quinoline-8-arylsulfonamides as disruptors of the Skp2–Cks1 protein–protein interaction (2026-01-01)
        • Integrated computational and biochemical identification of quinoline-8-arylsulfonamides as disruptors of the Skp2–Cks1 protein–protein interaction (2026-11-01)
        • Physical Therapists’ Self-Reported Perceptions of Bedside Manners in Saudi Arabia: A Mixed-Methods Study (2026-08-01)
        • Patients’ Perspectives on Bedside Manners in Physical Therapy in Saudi Arabia: A Mixed-Methods Study (2026-10-01)
        • Computational and experimental screening identifies 6-chloro-2-hydroxy-1-naphthaldehyde derivatives as disruptors of the HEG1–KRIT1 protein–protein interaction (2026-01-01)
        • Computational and experimental screening identifies 6-chloro-2-hydroxy-1-naphthaldehyde derivatives as disruptors of the HEG1–KRIT1 protein–protein interaction (2026-12-01)

        Teaching materials

          Last update date of the page content:

          survey_v2

          Cookies

          This website uses special cookies to ensure ease of use, improve your browsing experience, and clarify the terms and policies related to About user privacy. By continuing to browse this website, you acknowledge that you accept the use of cookies and the terms of the Privacy Policy